Home>Clininvent>Intermediates(UD)

Intermediates (Under Development)

CAS No Intermediate Name Name of the Product
[30131-16-9] 4-(4-Phenyl-1-butoxy)benzoic acid PRANLUKAST
[491833-28-4] (1R,2R)-2-amino-1-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-3-pyrrolidin-1-yl-propan-1-ol ELIGLUSTAT
[491833-36-4] (5S)-5-Phenyl-2-morpholinone hydrochloride
14640302 (1R,2R,1"S)-1-(2',3'-Dihydro-benzo[1,4]dioxin-6'-yl)-2-(2"-hydroxy-1"-phenyl-ethylamino)-3-pyrrolidin-1-yl-propan-1-ol
(1378388-16-9) (4S)-N-Boc-4-methoxymethyl-L-proline VELPATASVIR
(1335316-40-9) (2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
(1438383-89-1) 9-bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
(1426129-50-1) (R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl) carbaMate SACUBITRIL
(132507-89-2) (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol EFINACONAZOLE
(152628-02-9) 1,7'-dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole TELMISARTAN
Contact Us
R&D Centers in India:
Kolkata
+91 33 23673151/52
Business Development: India
contact.in@tcgls.com
USA
contact.us@tcgls.com
Europe
contact.eu@tcgls.com
Japan

contact.jp@tcgls.com